Literature DB >> 8593037

Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains.

J M Ossewaarde1, A de Vries, T Bestebroer, A F Angulo.   

Abstract

Mycoplasma contamination of biological materials remains a major problem. Most contaminations are caused by the use of Mycoplasma-contaminated cell lines. We adapted a Mycoplasma group-specific PCR to detect Mycoplasma contamination in cell lines and demonstrate its use in monitoring decontamination procedures with Mycoplasma-contaminated suspensions of Chlamydia spp. Three different methods were investigated: the use of Mycoplasma-specific antiserum in cell culture, physical separation by the combined use of enzymatic treatment and differential centrifugation, and the use of detergents. With these methods only incubation with Triton X-100 resulted in decontamination of Mycoplasma-contaminated suspensions of several laboratory strains of Chlamydia pneumoniae, C. pecorum, and C. trachomatis. Only one C. pneumoniae strain, UZG-1, was sensitive to Triton X-100 treatment. Since 39 of 40 throat swabs from patients with symptoms of an upper respiratory tract infection had positive reactions in the Mycoplasma group-specific PCR, this procedure could also have clinical significance in attempts to propagate C. pneumoniae strains from clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8593037      PMCID: PMC167802          DOI: 10.1128/aem.62.2.328-331.1996

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  20 in total

1.  Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae.

Authors:  P M Roblin; W Dumornay; M R Hammerschlag
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Basic local alignment search tool.

Authors:  S F Altschul; W Gish; W Miller; E W Myers; D J Lipman
Journal:  J Mol Biol       Date:  1990-10-05       Impact factor: 5.469

3.  Utility of an internal control for the polymerase chain reaction. Application to detection of Mycoplasma pneumoniae in clinical specimens.

Authors:  J P Ursi; D Ursi; M Ieven; S R Pattyn
Journal:  APMIS       Date:  1992-07       Impact factor: 3.205

4.  'Touchdown' PCR to circumvent spurious priming during gene amplification.

Authors:  R H Don; P T Cox; B J Wainwright; K Baker; J S Mattick
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

5.  Survival of Mycoplasma hyorhinis in trypsin solutions.

Authors:  A A Polak-Vogelzang; A F Angulo; J Brugman; R Reijgers
Journal:  Biologicals       Date:  1990-04       Impact factor: 1.856

6.  The elimination of mycoplasma from infected hybridomas by passaging in BALB/c mice.

Authors:  K Carroll; R O'Kennedy
Journal:  J Immunol Methods       Date:  1988-04-06       Impact factor: 2.303

Review 7.  Cytogenetic effects of mycoplasmal infection of cell cultures: a review.

Authors:  G J McGarrity; V Vanaman; J Sarama
Journal:  In Vitro       Date:  1984-01

8.  Elimination of Mycoplasma from cell cultures by means of specific bovine antiserum.

Authors:  A A Polak-Vogelzang; J Brugman; A D Osterhaus; R Reygers
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1987-04

9.  Evaluation of three methods for curing hybridomas from mycoplasma contamination.

Authors:  M Ravaoarinoro; J Lecomte
Journal:  Hybridoma       Date:  1988-02

10.  Development and clinical evaluation of a polymerase chain reaction test for detection of Chlamydia trachomatis.

Authors:  J M Ossewaarde; M Rieffe; M Rozenberg-Arska; P M Ossenkoppele; R P Nawrocki; A M van Loon
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

View more
  39 in total

1.  Analysis of genetic heterogeneity in Chlamydia trachomatis clinical isolates of serovars D, E, and F by amplified fragment length polymorphism.

Authors:  S A Morré; J M Ossewaarde; P H Savelkoul; J Stoof; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

2.  Temporal expression of type III secretion genes of Chlamydia pneumoniae.

Authors:  Anatoly Slepenkin; Vladimir Motin; Luis M de la Maza; Ellena M Peterson
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae.

Authors:  E A Castilla; R M Wadowsky
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

4.  Simultaneous detection and identification of common cell culture contaminant and pathogenic mollicutes strains by reverse line blot hybridization.

Authors:  Hui Wang; Fanrong Kong; Peter Jelfs; Gregory James; Gwendolyn L Gilbert
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

5.  Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood.

Authors:  Hiroyuki Yamaguchi; Ichiro Oshio; Takako Osaki; Satoru Kurata; Yoshimasa Yamamoto; Shigeru Kamiya
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

6.  Induction and inhibition of CPAF activity during analysis of Chlamydia-infected cells.

Authors:  Kirsten A Johnson; Jennifer K Lee; Allan L Chen; Ming Tan; Christine Sütterlin
Journal:  Pathog Dis       Date:  2015-02-06       Impact factor: 3.166

7.  Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron.

Authors:  Anatoly Slepenkin; Per-Anders Enquist; Ulrik Hägglund; Luis M de la Maza; Mikael Elofsson; Ellena M Peterson
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

8.  Centrosome abnormalities during a Chlamydia trachomatis infection are caused by dysregulation of the normal duplication pathway.

Authors:  Kirsten A Johnson; Ming Tan; Christine Sütterlin
Journal:  Cell Microbiol       Date:  2009-03-12       Impact factor: 3.715

9.  Fibroblast growth factor-inducible 14 (Fn14) is expressed in the lower genital tract and may play a role in amplifying inflammation during infection.

Authors:  Eugene S Han; Samrawit Mekasha; Robin R Ingalls
Journal:  J Reprod Immunol       Date:  2009-12-05       Impact factor: 4.054

10.  Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).

Authors:  Hiroyuki Yamaguchi; Shigeru Kamiya; Tomonori Uruma; Takako Osaki; Haruhiko Taguchi; Tomoko Hanawa; Minoru Fukuda; Hayato Kawakami; Hajime Goto; Herman Friedman; Yoshimasa Yamamoto
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.